BroadcastMed

BroadcastMed is the World's Most Innovative Healthcare Media Company

General Information
Company Name
BroadcastMed
Founded Year
1994
Location (Offices)
Farmington, United States +1
Founders / Decision Makers
Number of Employees
119
Industries
Social Media, Marketing
Funding Stage
Debt Financing
Social Media

BroadcastMed - Company Profile

is a pioneering healthcare media company with a focus on producing, promoting, and distributing groundbreaking clinical content to healthcare professionals. Established in 1994 in the United States, it continues to transform the future of medicine. The company recently secured a Debt Financing investment on 01 October 2022, with Churchill Asset Management as the main investor. With its innovative approach and strong investor backing, BroadcastMed stands poised to make a significant impact in the healthcare industry.

Taxonomy: Healthcare media, Digital strategies, Live surgeries, ORLive, Medical social media, Video production, Medical education, Content marketing

Funding Rounds & Investors of BroadcastMed (1)

View All
Funding Stage Amount No. Investors Investors Date
Debt Financing Unknown 1 Churchill Asset Management 01 Oct 2022

Latest News of BroadcastMed

View All

No recent news or press coverage available for BroadcastMed.

Similar Companies to BroadcastMed

View All
BiomedRx, Inc. - Similar company to BroadcastMed
BiomedRx, Inc. Healthcare Technology Solutions. Repair and maintenance of medical, medical imaging, and scientific laboratory equipment
Nucleus Medical Media - Similar company to BroadcastMed
Nucleus Medical Media The World's Most Watched Medical Animations
human Healthcare - Similar company to BroadcastMed
human Healthcare To make healthcare and medical knowledge accessible for all.
CIMS Medica India Pvt Ltd - Similar company to BroadcastMed
CIMS Medica India Pvt Ltd Empowering Healthcare Communities to Improve Patients' Outcomes
MedPage Today - Similar company to BroadcastMed
MedPage Today Healthcare is complicated. We explain it. Reposts, likes, and comments are not endorsements.